TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
DCGO

DocGo Inc

Healthcare · Medical Care Facilities

0.2469$ -9.6% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns DocGo Inc (DCGO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.1% of the shares are freely tradable; institutional investors hold 43.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 43.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 97.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 99Mio.

Largest Shareholders

Institutions

Institutions DCGO
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 3.78 3,728,207 +1.2 06/30/2026
P.a.w. Capital Corp 3.55 3,505,000 +16.6 06/30/2026
Knott David M Jr 2.71 2,670,850 +0.0 06/30/2026
Peapod Lane Capital LLC 2.53 2,500,118 +121.4 06/30/2026
Citadel Advisors Llc 2.39 2,353,610 -5.9 06/30/2026
Renaissance Technologies Corp 2.29 2,254,370 +49.3 06/30/2026
S Squared Technology, LLC 2.08 2,055,271 +0.0 06/30/2026
Acadian Asset Management LLC 1.82 1,792,971 +17.8 06/30/2026
AQR Capital Management LLC 1.73 1,708,962 +132.4 06/30/2026

Funds

Funds DCGO
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.70 2,664,541 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?